Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTENDED ANGIOCOMB
2008-006989-28Phase 4Completed
- Sponsor
- HUTCHMED
- Start
- Nov 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of thalidomide, celecoxib and etoposide in cancer, sponsored by HUTCHMED. Primary endpoint: overall survival. Started Nov 2008; status: completed.
02
Drugs
thalidomidecelecoxibetoposide
03
Conditions
cancer
Beyond the preview
Go deeper on 2008-006989-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006989-28.